Market Research Report
Global Drug-Eluting Stents Market
|Published by||BCC Research||Product code||969286|
|Published||Content info||127 Pages
Delivery time: 1-2 business days
|Global Drug-Eluting Stents Market|
|Published: November 4, 2020||Content info: 127 Pages||
The global market for drug-eluting stents should grow from $6.7 billion in 2019 to $9.3 billion by 2024 at a compound annual growth rate (CAGR) of 6.8% during the period of 2019-2024.
The global market for polymer-based drug-eluting stents should grow from $4.1 billion in 2019 to $5.4 billion by 2024 at a CAGR of 6.0% during the period of 2019-2024.
The global market for polymer-free drug-eluting stents should grow from $2.7 billion in 2019 to $3.9 billion by 2024 at a CAGR of 7.9% during the period of 2019-2024.
This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of product, application and end user.
By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.
By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.